Within-patient HIV populations evolve rapidly because of a high mutation rate, short generation time, and strong positive selection pressures. Previous studies have identified "consistent patterns" of viral sequence evolution. Just before HIV infection progresses to AIDS, evolution seems to slow markedly and the genetic diversity of the viral population drops. This evolutionary slowdown could be caused either by a reduction in the average viral replication rate or because selection pressures weaken with the collapse of the immune system. The former hypothesis (which we denote "cellular exhaustion") predicts a simultaneous reduction in both synonymous and non-synonymous evolution, while the latter hypothesis (denoted "immune relaxation") predicts that only non-synonymous evolution will slow. In this paper, we present a set of statistical procedures for distinguishing between these alternative hypotheses using DNA sequences sampled over the course of infection. The first component is a new method for estimating evolutionary rates that takes advantage of the temporal information in longitudinal DNA sequence samples. Second, we develop a set of probability models for the analysis of evolutionary rates in HIV populations in vivo. Application of these models to both synonymous and non-synonymous evolution affords a comparison of the cellular exhaustion and immune relaxation hypotheses. We apply the procedures to longitudinal data sets where sequences of the env gene were sampled over the entire course of infection. Our analyses (1) statistically confirm that an evolutionary slowdown occurs late in infection, (2) strongly support the immune relaxation hypothesis, and (3) indicate that the cessation of non-synonymous evolution is associated with disease progression. 
Introduction
Describing and quantifying the forces that shape HIV evolution within patients is critical to both (1) a mechanistic understanding of the interaction between the virus population and the immune system and (2) the design and implementation of clinical intervention strategies. Viral adaptation to the host environment is thought to play a causal role in HIV pathogenesis (Nowak et al. 1991; Tersmette et al. 1989; Wodarz, Klenerman, and Nowak 1998; Wolinsky and Learn 1999) . Therefore, precisely characterizing the adaptive changes that occur during chronic infection should help elucidate the series of evolutionary events that lead to disease progression (e.g. Ross and Rodrigo 2002; Williamson 2003) . Viral evolution also confounds medical treatment efforts because HIV populations quickly evolve resistance to antiviral drugs (see Shankarappa 1999 for review). Only those strategies that directly account for viral evolution in response to the intervention have been successful. For instance, highly active antiretroviral therapy (HAART) has proven to be a very successful long-term treatment strategy, primarily because the introduction of "drug cocktails" greatly slows the evolution of drug resistance (Finzi et al. 1997; Wong et al. 1997 ). Clearly, a detailed description of within-patient viral evolution is necessary to understanding the dynamics of HIV infection.
The most detailed information regarding viral evolution in vivo comes from longitudinal studies, in which samples of viral DNA or RNA are taken from the same infected patient over time (e.g. Balfe et al. 1990; Wolfs et al. 1991; Holmes et al. 1992; Zhang et al. 1993) . We use "longitudinal data set" to refer to the set of all sequences sampled from a single patient over time. The temporal structure of longitudinal data sets allows researchers to determine the immediate consequences of specific events in viral evolution. Examples include the evolution of drug resistance (e.g. Larder, Darby, and Richman 1989) , the evolution of viral phenotypes that escape the current immune response (McMichael and Phillips 1997; Goulder et al. 2003) , and disease progression (Viscidi 1999; Ross and Rodrigo 2002; Williamson 2003) . Shankarappa et al. (1999) published an extensive collection of longitudinal data sets including data from nine infected individuals. Sequences of the C2-V5 region of the envelope gene (env) were sampled over the entire course of infection in each patient. Samples were taken at approximately 10-month intervals with 10-20 sequences determined per sample. The authors assert that the most important pattern evident in their data is "consistent stages" of viral evolution (Shankarappa et al. 1999, fig. 6 ). In the first stage, both env nucleotide diversity and divergence from the founding population increase linearly. During the next stage, which lasts on average ~2 years, nucleotide diversity either stabilizes or declines, while divergence continues to accumulate. And in the final stage, divergence also stabilizes-i.e. env sequence evolution nearly comes to a halt. This final stage usually begins less than 1 year before the onset of clinical AIDS (CD4 + T-cell counts <300 cells/µl). Further, Shankarappa et al. (1999) found close associations with these patterns and the emergence of the X4 viral genotype, an important indicator of disease progression (Schuitemaker et al. 1992) . They noted that the time of peak diversity coincided with the initial emergence of X4 viruses, and divergence stabilization coincided with the X4 viruses reaching their highest frequency. In this paper, we investigate the causal factors leading to these consistent patterns of env evolution. In particular, we will address what causes the evolutionary rate to slow so dramatically toward the end of infection.
We consider two alternative hypotheses to explain divergence stabilization. The first hypothesis, which we refer to as cellular exhaustion, proposes that the viral generation time increases as the primary target cell populations (CD4 + T-cells) become depleted. As the generation time increases, the evolutionary rate slows and divergence stabilizes. Several factors could contribute to the increase in generation time coincident with target cell depletion. First, as CD4 + T cells are depleted late in infection, a greater proportion of replication cycles might go through other infectable cell types, such as macrophages and CD4 + memory T cells. The intracellular stage of the viral life cycle occurs much more slowly in these alternative cell types (Finzi et al. 1997 (Finzi et al. , 1999 , and a shift to increasing usage of these cell types can have a major impact on the viral replication rate (Kelly 1996; . Also, the average time of the virion stage of the viral life cycle could increase simply because target cells are rarer and encountered less frequently by virions. This would also increase the overall generation time.
The second hypothesis, which we refer to as immune relaxation, is that the evolutionary rate slows because infection disrupts immune function. This, in turn, diminishes positive selection pressure to escape immune response (Bonhoeffer, Holmes, and Nowak 1995) .
Immune-mediated positive selection is thought to be an important force driving evolution in the HIV genome, especially in the env gene (e.g. Wolfs et al. 1990; Holmes et al. 1992; Bonhoeffer, Holmes, and Nowak 1995; Wolinsky et al. 1996; Richman et al. 2003) . As the immune system is disrupted, the evolutionary rate could fall back closer to the expected neutral rate. This hypothesis, if correct, would have important implications for HIV evolution and dynamics. First, it would suggest that the primary selective force acting on env is the immune system itself. This result would not be surprising as it is generally assumed that the immune system is the primary source of positive selection pressure. However, the importance of immune-mediated selection relative to other selective pressures has been difficult to establish. Second, and perhaps more importantly, the immune relaxation hypothesis suggests that the parts of the immune system disrupted by infection (most notably, CD4 + T-cells) play an indispensable role in responding to epitopes coded for by env and in driving env sequence evolution. Thus, the immune relaxation hypothesis implies a feedback loop, with the virus directly impairing HIV-specific responses.
Immunological evidence points to such an interaction between the virus and HIV-specific CD4 + memory T cells (Douek et al. 2002) . However, the evolutionary significance of this interaction
has not yet been established.
We can differentiate between cellular exhaustion and immune relaxation by contrasting patterns of divergence at non-synonymous and synonymous sites within env. The cellular exhaustion hypothesis, because it is based on an increase in the viral generation time, predicts that both non-synonymous and synonymous divergence will slow down at the time of divergence stabilization. In contrast, the immune relaxation hypothesis predicts a slow-down in only the non-synonymous sites because the synonymous sites are not subject to immune-mediated selection. In this paper, we measure the initial divergence rate and the time of divergence stabilization for both non-synonymous and synonymous sites in the Shankarappa et al. (1999) data sets in hopes of distinguishing between the two alternative hypotheses of divergence stabilization.
When Shankarappa et al. (1999) initially identified the "consistent patterns," the times of peak diversity and divergence stabilization were estimated by eye. Given the stochastic nature of viral evolutionary dynamics, this subjective procedure can be problematic. Mayer-Hamblett and Self (2001) addressed this problem for changes in viral diversity by using regression models to estimate the time of peak diversity and to test hypotheses regarding changes in the level of diversity. Here, we develop a statistical procedure for characterizing changes in divergence rates based on a simple probability model. This method not only allows us to test the cellular exhaustion and immune relaxation hypotheses, it also allows more accurate association between divergence stabilization and other aspects of infection (e.g. disease progression) and more accurate measures of the divergence rate.
In the next section, we develop a statistical framework for the analysis of divergence in longitudinal data sets and apply it to the longitudinal data from eight of the HIV infected patients studied by Shankarappa et al. (1999) . We derive a diffusion model to predict the likelihood of the various evolutionary trajectories observed in the data, either with or without divergence stabilization. This model serves as the underpinning for a maximum likelihood estimation routine, which allows estimation of evolutionary parameters such as the mean and variance of divergence rate. It also provides a rigorous statistical test (a likelihood ratio) for the existence of divergence stabilization within patients. We use a parametric bootstrapping routine to evaluate the significance of the likelihood ratio tests. Finally, we test the assumptions of our approach using forward population genetic simulations.
Methods
Measuring divergence--We require an accurate method for measuring divergence in order to detect potentially subtle changes in the rate of divergence within a longitudinal data set. The typical approach for measuring divergence between sequences is to apply a nucleotide substitution model that corrects for saturation, i.e. a prevalence of multiple substitutions at the same nucleotide position (Graur and Li 2000, ch. 3). This correction is important, because saturation itself will lead to an apparent reduction in the rate of divergence through time.
Unfortunately, the correction applied can be very sensitive to both the type of substitution model chosen and the method used (if any) to account for rate variation. Furthermore, the nucleotide substitution process in the HIV genome is fairly complex, e.g. the nucleotide frequency profile is A-rich (A≈40%) and the A_C transversion is more common than some transitions (Hillis, Huelsenbeck, and Cunningham 1994) . To account for these peculiarities, it is necessary to apply complicated substitution models (Moriyama et al. 1991) , which only increases the uncertainty due to model selection. For instance, Anderson et al. (2001) found that the best approximating substitution model for the gp120 region of env is a general time-reversible model (GTR) with eight parameters plus one parameter for gamma-distributed rate variation.
We take an alternative approach for measuring divergence. The temporal structure of longitudinal data allows us to infer multiple substitutions at individual sites by simple inspection of the time series. This approach is sound as long as sampling times are frequent enough so that multiple substitutions do not typically occur in between time points. We have developed a simple algorithm for determining when multiple substitutions have occurred between a given sequence and the progenitor sequence. Also, we have developed an algorithm for using the temporal information in the data to more accurately delineate between non-synonymous and synonymous substitutions when more than 1 change has occurred in the same codon. These methods are described in detail in the Appendix.
Data and analysis scheme for each patient--Nucleotide sequences in longitudinal data sets were obtained for all patients from the Shankarappa et al. (1999) study except for patient 11, which was excluded due to smaller sample sizes and infrequent sampling. First, the progenitor sequence in each patient was approximated as the consensus sequence of the earliest sample.
Next, the progenitor sequence and all of the sequences in the remaining time points were aligned using the default parameters of ClustalX (Thompson et al. 1997) , then hand-corrected. In data sets from most patients, there were regions that could not be aligned for the whole data set; these regions were excluded from the analysis. In terms of the nucleotide position in the progenitor sequence (excluding gaps), these regions are: p1 (574-588), p2 (382-411, 577-597), p5 (573-579), p8 (382-387, 565-585), p9 (392-414, 558-594) . After alignment, non-synonymous, synonymous, and total nucleotide divergence values were tabulated for each sequence using the methods outlined in the Appendix. Our estimates of mean divergence (synonymous and nonsynonymous) within each patient are given as a function of time in Figure 1 . The individual sequence values were used in the series of statistical procedures described below. Nucleotide sequence alignments and the source code for the programs that implement the divergence tabulation are available from the corresponding author.
Probability model for divergence--We assume that the mean divergence of the entire population is governed by a diffusion process (Brownian motion) with drift parameter j (the divergence rate) and diffusion parameter s 2 (the variance in the divergence rate). Hereafter, we will refer to the mean divergence of the entire population as the "population divergence." In a small interval of time (Dt), the change in population divergence is a normally distributed random variable with expectation j*Dt and variance s 2 *Dt. This model allows random fluctuations in the realized rate of evolution even when the underlying rate is constant. The population divergence can even decline in some time intervals, although the whole process is subject to the boundary condition that divergence must be greater than or equal to zero for t > 0. Also note that the variance parameter s 2 is not directly related to any measure of within-population genetic variation; rather, it describes the variance in population divergence among replicate populations.
Our Constant Rate Model assumes that the divergence rate (j) is constant throughout infection. This serves as a null model for testing divergence stabilization. Let u(y, t) be the probability density function of the population divergence, y, at time t. u is governed by the following partial differential equation:
, where d is the Dirac delta function, and a reflecting boundary at y = 0. Our Divergence Stabilization Model involves one additional parameter,t, which is the time of divergence stabilization. For t <t, the population divergence (y) follows a diffusion with drift parameter j and variance s 2 . At time t however, the drift parameter changes from j to 0, while the diffusion parameter remains unchanged.
If we ignore the boundary condition, the solution of equation (1) is a normal density function. For the Constant Rate Model, the mean is j t and the variance is s 2 t. The same variance is obtained for the Divergence Stabilization Model, but the mean is j t for t < t and j t for t >t. We use this approximation to develop the maximum likelihood framework described below. However, the boundary is explicitly included in the parametric bootstrapping simulations that we use to evaluate our likelihood ratio tests.
Two sorts of stochasticity must be considered: evolutionary fluctuations and sampling variation. Let i = 0, 1, 2, … k denote the samples taken at different time points, in chronological order. In each patient, we use sample 0 to infer the progenitor sequence of all subsequent samples. Early in infection, the viral population is genetically homogeneous within the env gene (Zhang et al. 1993) . Therefore, we approximate the progenitor sequence as the consensus sequence of sample 0. For samples 1 through k, let t i denote the time (since seroconversion) that the sample was taken. Let y i denote the (unobserved) population divergence at time t i , measured as the number of differences per site from the progenitor. Let n i be the sample size of each time point. Let x ij denote the divergence of sequence j in sample i, in terms of the number of differences per site from the progenitor. Conditional on each y i , we assume that the x ij are also normally distributed:
where s i 2 is the variance in divergence among viruses within the population at the i th sampling time. To obtain the unconditional distribution of x ij , we integrate over all y i :
The joint distribution of all x ij from a single longitudinal dataset follows a multinormal distribution. The covariance between two observations in the same sample is
where j 1 ≠ j 2 . The covariance between observations at different time points is
There is a well-developed theory for estimation of parameters from multinormal data (Searle, Casella, and McCulloch 1992 
where q is the vector of expected values of each of the x ij 's (E[x ij ]=j t i ), V is the variancecovariance matrix containing the terms described in equations (4) and (5), n is the total number of sequences sampled in all of the time points, and |*| denotes the determinant of a matrix.
The Divergence Stabilization Model contains k+3 parameters: k population variances, j, s 2 , and t. The only effect this new parameter has on the likelihood function is within the vector of expected values. Call this new vector, p:
Again, the vectors of expected values are concatenated sequentially. The log-likelihood function for the divergence stabilization model is:
Numerical values for the log-likelihoods (equations 6, 8) were determined using a program written in the C programming language and executed on a series of Dell Pentium 4 computers.
We used the standard estimator for the variance of a normal population for the s To fit the Divergence Stabilization Model for a single data set, we conducted a series of optimizations over the range of possible values for t. We started with the largest possible value for t, which is t k , then maximized the log-likelihood function with a fixed value of t, i.e. the profile log-likelihood. From this optimization, we recorded the maximum likelihood estimates for j and s 2 and the maximum log-likelihood value. We then reduced the value of t by 1 month and maximized the profile log-likelihood again by finding optimal values for j and s
2
. This process was repeated with each successive iteration considering a lower value of t. An example of this procedure, the actual analysis of non-synonymous evolution in Patient 1, is given in Figure 2 . Thus, for both synonymous and non-synonymous evolution within each patient, the model fitting procedure yields a set of log-likelihood values defined for each possible value of t.
For both the constant rate and divergence stabilization models, our search procedure rapidly converged on the same maximum likelihood estimates from different start values.
However, it may be possible to develop more efficient search algorithms (perhaps necessary for larger datasets) by noting that both models are essentially "Gaussian state-space models" (Durbin and Koopman 2001) . Such models have been used extensively for the analysis of time series data in economics and engineering. The Kalman filter might be adapted to provide a general framework for both prediction and likelihood-based parameter estimation of models like those described here (Harvey 1989, ch. 3) . The fact that we did not incorporate the boundary condition in equations (6) and (8) implies that our log-likelihood values are only approximate. However, this should not impact the hypothesis testing described in the next section. The same assumption applies to both the CR and DS models and the relative fits of these models depend on sequence data from late in infection, by which time the boundary is irrelevant. Both evolutionary variability and small sample sizes limit the power of tests based on individual patients. Thus, to distinguish immune relaxation from cellular exhaustion, we also performed two analyses that combine data across patients. These combined analyses are possible because evolution in different patients is independent. As a consequence, we can sum the (maximum) log-likelihoods across patients for the different evolutionary models. This allows us to compare the constant rate and divergence stabilization models with combined LRTs using all the non-synonymous or synonymous data simultaneously. If divergence stabilization occurs in all patients, these combined LRTs will have more power to detect it. In the combined analyses, the log-likelihood value for the constant rate model is simply the sum of the maximum loglikelihood values for this model within each patient.
Hypothesis testing-
We consider two different versions of divergence stabilization as alternatives to the constant rate model. The first version posits that divergence stabilization is directly related to disease progression. In each patient, divergence stabilization occurs at time T p + a, where T p is the time of disease progression, and a is constant across all patients. We define T p as the first time at which the patient's CD4 + T-cell count dropped below 300 cells/ml. Hereafter, we will refer to this model as the single-a divergence stabilization model. The maximum log-likelihood for the model is obtained by finding the value for a that maximizes the sum of patient specific log-likelihoods with t = T p + a within each patient. The second variant of the divergence stabilization model, which we refer to as the free-t model, allows the time of divergence stabilization (t ) to vary among patients without constraint.
If the constant rate model were true, we might expect the the likelihood ratio test statistic to follow a chi-square distribution with the number of degrees of freedom equal to the difference in the number of parameters between the models that are being compared. In the present context, the comparison between the single-a divergence stabilization model and constant rate models would involve a single degree of freedom because the more complicated model adds only one parameter (a). The degrees of freedom for the free-t model would be equal to the number of patients, because t is estimated separately in each patient. Unfortunately, the asymptotic theory that justifies use of the chi-square distribution for evaluating LRT statistics is not applicable in this case. The parameters s It is straightforward to simulate divergence under either the Constant Rate or Divergence Stabilization for any particular set of parameter values. First, we simulated the population divergence recursively over small time steps (Dt=0.1 months): starting at y=0 at time 0, the population divergence at the next time step, y(t+Dt), is drawn from a normal distribution with mean y(t)+j*Dt and variance s 2 *Dt. To incorporate the boundary, negative values were reset to 0. Next, for the sampling times (t i ) in each particular patient, the divergence values for individual sequences were simulated following equation (2) using the simulated population divergences, where the sampling variance was estimated from the data. For the analyses that consider data from each patient separately, we used our maximum likelihood estimates for j and s 2 from the fitted Constant Rate Model to produce a set of 500 simulated datasets for each patient in the Shankarappa et al. (1999) study. We then fitted both models to each simulated dataset, recorded the maximum log-likelihoods for each model, and calculated the LRT (see Kelly 2003 for an application of the parametric bootstrap to Multi-normal data). The null distributions for our single-a and free-t LRTs were obtained by combining simulation results from the individual patients. We repeatedly reconstituted whole datasets (involving 8 patients)
by randomly selecting simulated data sets from each patient. The combined LRTs were calculated for these reconstituted datasets and the values recorded. This procedure was repeated 10,000 times to estimate the distributions.
Forward Simulations-In developing our constant rate and divergence stabilization models, we have made two main assumptions: (1) that the mean divergence of the entire population is accurately described by a diffusion process, and (2) that the boundary condition at y = 0 does not strongly affect our method of inference. In order to assess the validity of these assumptions under different evolutionary scenarios, we performed forward population genetic simulations of sequence evolution. These simulations incorporated natural selection, recombination, and mutation.
Each iteration proceeded as follows: we started with a genetically homogeneous population of 2N sequences, each of length L. This formed the ancestral population.
Reproduction proceeded according to a Wright-Fisher model for diploids-i.e. with non-overlapping generations, random mating, and a constant population size. Mutation occurred at rate m per sequence (not per base pair) per generation, and the mutation rate was uniform over the whole sequence. When a mutation occurred at a previously mutated site, it reverted back to the ancestral state. Recombination occurred at rate r per sequence per generation, and recombination was modeled as a crossover process occurring only at homologous sites within diploid individuals. We did not allow insertions or deletions. For the simulations with natural selection, a certain proportion of new mutations, p s , were subject to selection, and the remainder were neutral. The selection coefficient s describes the relative advantage of the new mutation over the ancestral allele at that site. The selective effects of multiple mutations within a sequence were combined multiplicatively. At 10-month intervals (the approximate interval between sampling in the Shankarappa et al. (1999) study) the mean divergence of the entire population was tabulated relative to the ancestral population, not correcting for back mutation.
This was repeated up to 100 months. For each parameter combination, the diploid population size and sequence length were held constant (N=1000, L=650), and we assumed that 1 generation occurred every 2 days , Fu 2001 , Drummond et al. 2002 . The mutation rate, m, was selected such that the sequences diverged by ~1% per year, which is typical of the Shankarappa et al. (1999) data. The simulations were iterated 500 times for each parameter combination. Figure 3 shows the results of the forward simulations for several different combinations of recombination and selection parameters. The (unbounded) diffusion models presented above predict that, among replicate populations: (1) both the mean and variance of population divergence should increase linearly with time, (2) at any time point, the population divergence should be normally distributed, and (3) due to the memoryless property of the diffusion, the covariance in population divergence among two different time points should equal the variance of the earlier time point. Figure 3c and Figure 3d indicate that prediction (1) holds for different recombination rates and selection regimes: both the mean and variance increase linearly. Figure   3a shows the distribution of population divergence at different time points for the case of neutral evolution with a high recombination rate, along with a fitted normal distribution. The normality prediction seems to hold very well. The same pattern is observed for the other parameter combinations, including those with selection. And finally, Figure 3b plots the covariance between time points as a function of the variance of the earlier time point. The agreement with prediction (3) is quite good. Taken together, our forward simulations indicate that, for a range of evolutionary models, mean population divergence is very well approximated by a diffusion, and our assumption regarding the boundary does not have a strong affect on our probability model.
Results
Figure 1 suggests that (1) in some patients, non-synonymous divergence seems to stabilize, whereas synonymous divergence does not, (2) non-synonymous divergence stabilization seems to coincide with disease progression, and (3) the rate of non-synonymous divergence tends to be higher than the rate of synonymous divergence. These observations are confirmed by our statistical analysis. Parameter estimates, LRT statistics, and P-values from our combined analyses (free-t and single-a) are shown in Table 1 . Our most striking result is that, in the free-t and single-a analyses, we find strong evidence for divergence stabilization at nonsynonymous, but not synonymous, sites. For instance, in our free-t analysis we reject the constant rate model (P=0.0014) for non-synonymous sites, but we find little evidence for divergence stabilization at the synonymous sites (P=0.11). Results from individual analyses are shown in Table 2 . When the data was not combined across patients, we lacked sufficient power to reject the constant rate model in most data sets. However, in 6 of 8 patients, the LRT statistic of the non-synonymous data set is higher than that of the synonymous data set.
We use our single-a model to explore the relationship between divergence stabilization and disease progression. We find strong evidence that disease progression and divergence stabilization at non-synonymous sites are tightly associated, but no evidence of a similar relationship at synonymous sites. We reject the constant rate model (P=0.0002) in favor of the single-a model for non-synonymous sites, but we find no evidence (P=0.55) for divergence stabilization at the synonymous sites. Furthermore, when we estimate the non-synonymous 
Discussion
Our analyses suggest that divergence stabilization-i.e. the reduction in evolutionary rate coincident with disease progression-is due primarily to relaxation of positive selection rather than an increase in the average generation time. We reject the constant rate model for nonsynonymous, but not synonymous, sites. Both the single-a analysis and the separate analyses of individual patients suggest a strong relationship between the time of disease progression and the time of divergence stabilization for non-synonymous, but not synonymous, sites. These results are predicted by the immune relaxation hypothesis, and they are inconsistent with the cellular exhaustion hypothesis.
The support for the immune relaxation hypothesis in the present set of analyses corroborates several common ideas about HIV evolution. First, our results are fully consistent with the notion that the immune system is the primary agent of positive selection in the C2-V5 region of env (Bonhoeffer, Holmes, and Nowak 1995; Wolinsky 1996; Ross and Rodrigo 2002) .
Second, our results suggest that HIV disrupts those agents of the immune system that play a critical role in controlling infection. Immunological studies support the existence of such a feedback loop. Douek et al. (2002) found that the virus preferentially infects HIV-specific CD4 + T cells. Because HIV-specific CD4 + T cells are thought to play an important role in controlling viremia (e.g. Rosenberg et al. 1997) , Douek et al. (2002) proposed that this viral specificity contributes to the uncontrolled viral replication that coincides with progression to AIDS. Our analyses further suggest that the interaction between the virus and HIV-specific immune effectors, such as HIV-specific CD4 + T cells, alters course of viral evolution.
In a previous analysis, Bonhoeffer , Holmes, and Nowak (1995) observed a decrease in the d N /d S ratio of the env gene V3 loop over time within a single infected patient. They attributed this to a reduction in selection intensity over the course of infection. However, Nielsen (1999) pointed out that such a change could also be due to the non-equilibrium dynamics of an evolving virus population: because the population is initially genetically homogeneous, it takes some time for new mutations to spread to detectable frequencies, where they could be counted as substitutions. This transition time will be longer for neutrally-evolving synonymous mutations than for positively-selected non-synonymous mutations, so the d N /d S ratio would decrease over time to some equilibrium, without a change in selection intensity. In contrast, we do not expect non-equilibrium dynamics to have a large effect on our analyses. We follow divergence at each type of site separately. The founder effect of initial infection will cause the divergence rate at each type of site to increase monotonically until it reaches some equilibrium.
It will not cause the divergence rate to drop back to 0, as is the case in our divergence stabilization model. Therefore, our test for a decrease in the divergence rate is conservative with respect to the founder effect.
Relation to other methods--Our diffusion based analysis is complementary to three other approaches that have been taken in analyzing longitudinal data sets: phylogenetic methods, coalescence theory, and regression models. Phylogenetic methods allow powerful inferences regarding natural selection and other population processes. Indeed, a phylogenetic tree has become the de facto method for summarizing the information in a longitudinal data set (e.g. Wolinsky et al. 1996; Ganeshan et al. 1997; Markham et al. 1998; Shankarappa et al. 1999; Yamaguchi-Kabata and Gojobori 2000) , and phylogenetic methods based on codon substitution models (Nielsen and Yang 1998) have been used to identify widespread positive selection in longitudinal data sets (e.g. Zanotto et al. 1999, Ross and . A potential difficulty in applying phylogenetic methods to longitudinal data sets is that recent studies suggest that the recombination rate of HIV populations in vivo is high (Jung et al. 2002 , Wain-Hobson et al. 2003 . Phylogenetic methods generally assume no recombination. Although the effects of violating the no-recombination assumption are not fully understood, simulations have shown that even small amounts of recombination have a large effect on tree statistics, and can exaggerate of the degree of substitution rate heterogeneity (Schierup and Hein 2000) . Also, unrecognized recombination can cause codon-based phylogenetic methods to falsely identify positive selection (Shriner et al. 2003; Anisimova, Yang, and Nielsen 2003) . In general, results from phylogenetic analyses of longitudinal data sets can be difficult to interpret in the presence of recombination.
A second approach taken in analyzing longitudinal data sets is coalescence theory (Kingman 1982; Hudson 1983) , which has been adapted specifically for longitudinal data sets ("the serial coalescent" of Rodrigo and Felsenstein 1999) . Because the serial coalescent is based on a population process, it can be used to estimate important population parameters, such as the within-patient effective population size (Leigh-Brown 1997 , Seo et al. 2002 , Drummond et al. 2002 and the generation time , Fu 2001 , Drummond et al. 2002 . The coalescent approach makes two assumptions which may be violated in the env gene. First, current implementations of the serial coalescent assume no recombination. Second, the serial coalescent assumes neutral evolution, whereas natural selection is thought to play an important role in env. Modifications to the coalescent that allow for selection (e.g. Neuhauser and Krone 1997, Barton and Etheridge 2004) are not applicable to the type of selection common in HIV:
strong positive and diversifying selection at many linked sites sites.
Regression modeling is a third approach that has been taken in analyzing longitudinal data from HIV infected patients. Mayer-Hamblett and Self (2001) describe a set of regression models for characterizing genetic diversity within and among samples of sequences. Applying these models to the Shankarappa et al. (1999) data set, they conclude that viral diversity (variation among sequences within a single sample) increases over most of the course of infection, but declines at the end. However, in contrast to the analysis presented here, they failed to confirm a stabilization of divergence towards the end of infection. The differing conclusions of our study and that of Mayer-Hamblett and Self (2001) probably stem, in part, from differences in our respective modeling approaches. However, the most important difference is likely that we distinguish synonymous and non-synonymous changes. Only the latter seems to provide compelling evidence of divergence stabilization.
By following the mean population divergence from the progenitor sequence rather than the genealogy of all sequences, our analysis is fairly permissive in terms of population processes such as recombination and natural selection. Our null model requires only that the underlying rate of substitution is approximately constant through time. For example, consider the case of two linked loci subject to neutral evolution, sampled in a single individual. In this situation, past recombination events will not affect the number of substitutions at either locus (or the total number of substitutions), simply because each locus is expected to experience the same number of generations whether or not recombination has occurred. Also, consider the case of frequent selective sweeps-i.e. rapid fixation events of advantageous mutations. If the rate of advantageous mutation is constant, then the rate of substitution will also be constant. Population genetic simulations support these arguments: the diffusion model seems to provide an adequate description of mean population divergence through time even when both recombination and natural selection are operating.
The sufficiency of the diffusion models stems largely from the fact that we are considering only one aspect of the complex data structure from longitudinal studies. The models make no prediction about the pattern of variation among sequences within a single sample, either in the extent to which they differ from the progenitor or from each other. Such measures of viral diversity exhibit large fluctuations over the course of infection, even within a single patient (Shankarappa et al. 1999; Mayer-Hamblett and Self 2001) . Thus one advantage of our approach is that it is relatively insensitive to these large-scale fluctuations. One disadvantage, however, is that such fluctuations in viral diversity may play an important role in disease progression (Nowak et al. 1991) , and our models cannot address this problem. A major challenge in the analysis of longitudinal data sets lies in developing methods that characterize changes in divergence, diversity, and the relationship between the two. To summarize, when the second derived nucleotide is first observed, we infer that it has arisen from whatever character state is found in the closest (in terms of pairwise differences) previous sequence. This routine does not account for back mutation.
In addition to correcting for multiple substitutions, we can also use the temporal information in longitudinal data sets to more accurately delineate between non-synonymous and synonymous substitutions. A common problem in DNA sequence analysis lies in counting the numbers of non-synonymous and synonymous substitutions when there have been multiple changes in a single codon. Consider the following example for the changes in a particular codon: AGT (Ser) _ GGA (Gly 
